EGFR-IN-34

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

EGFR-IN-34 

EGFR-IN-34 是一种有效的EGFR抑制剂。EGFR-IN-34 是一种低毒副作用的抗肿瘤药物。EGFR-IN-34 是丙烯酰胺衍生物。表皮生长因子受体 (EGFR) 的过度表达和突变已被清楚地证明会导致无法控制的细胞生长,并且与大多数癌症疾病,尤其是 NSCLC 的进展有关。EGFR-IN-34 具有研究 EGFR 突变相关疾病的潜力 (摘自专利 WO2021185348A1,化合物 12)。

EGFR-IN-34

EGFR-IN-34 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

EGFR-IN-34 is a potent inhibitor of EGFR. EGFR-IN-34 is an anti-tumor drug with low toxic side effects. EGFR-IN-35 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-34 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 12)[1].

分子量

490.98

Formula

C26H27ClN6O2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Yihan Wang, et al. Substituted acrylamide derivatives and compositions thereof and their uses. Patent WO2021185348A1.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务